Verve Therapeutics, Inc. (VERV) Debt-to-equity % 2022 - 2024

Historical data

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Verve Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from 2022 to 2024.
Verve Therapeutics, Inc. Debt-to-equity for the quarter ending March 31, 2024 was 27.4 %, a 28.5% increase year-over-year.

Debt-to-equity, Quarterly Data (%)

Period	Value	YoY Chg	Change %	Start Date	End Date
Q1 2024	27.4	+6.09	+28.5%		Mar 31, 2024
Q4 2023	27.2	+9.89	+57%		Dec 31, 2023
Q3 2023	26.6	+13.7	+106%		Sep 30, 2023
Q2 2023	24.2	+17	+237%		Jun 30, 2023
Q1 2023	21.3	+15.2	+244%		Mar 31, 2023
Q4 2022	17.4				Dec 31, 2022
Q3 2022	12.9				Sep 30, 2022
Q2 2022	7.19				Jun 30, 2022
Q1 2022	6.2				Mar 31, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.